Literature DB >> 12065503

Neisseria lactamica protects against experimental meningococcal infection.

Kerry J Oliver1, Karen M Reddin, Philippa Bracegirdle, Michael J Hudson, Ray Borrow, Ian M Feavers, Andrew Robinson, Keith Cartwright, Andrew R Gorringe.   

Abstract

Immunological and epidemiological evidence suggests that the development of natural immunity to meningococcal disease results from colonization of the nasopharynx by commensal Neisseria spp., particularly with N. lactamica. We report here that immunization with N. lactamica killed whole cells, outer membrane vesicles, or outer membrane protein (OMP) pools and protected mice against lethal challenge by a number of diverse serogroup B and C meningococcal isolates in a model of bacteremic infection. Sera raised to N. lactamica killed whole cells, OMPs, or protein pools were found to cross-react with meningococcal isolates of a diverse range of genotypes and phenotypes. The results confirm the potential of N. lactamica to form the basis of a vaccine against meningococcal disease.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12065503      PMCID： PMC128090          DOI： 10.1128/IAI.70.7.3621-3626.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  29 in total

1.  Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species.

Authors:  G Troncoso; S Sánchez; M Moreda; M T Criado; C M Ferreirós
Journal:  FEMS Immunol Med Microbiol       Date:  2000-02

2.  Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes.

Authors:  J J Kim; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes.

Authors:  A K Lehmann; A R Gorringe; K M Reddin; K West; I Smith; A Halstensen
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica.

Authors:  P G Coen; K Cartwright; J Stuart
Journal:  Int J Epidemiol       Date:  2000-02       Impact factor: 7.196

5.  Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Authors:  R Borrow; N Andrews; D Goldblatt; E Miller
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Septicemia due to Neisseria lactamica.

Authors:  H D Wilson; T L Overman
Journal:  J Clin Microbiol       Date:  1976-09       Impact factor: 5.948

7.  Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease.

Authors:  S F Olsen; B Djurhuus; K Rasmussen; H D Joensen; S O Larsen; H Zoffman; I Lind
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

8.  Purification of rough-type lipopolysaccharides of Neisseria meningitidis from cells and outer membrane vesicles in spent media.

Authors:  X X Gu; C M Tsai
Journal:  Anal Biochem       Date:  1991-08-01       Impact factor: 3.365

9.  Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.

Authors:  R Gold; I Goldschneider; M L Lepow; T F Draper; M Randolph
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  25 in total

1.  Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Authors:  Margaret Anne J Gidney; Joyce S Plested; Suzanne Lacelle; Philip A Coull; J Claire Wright; Katherine Makepeace; Jean-Robert Brisson; Andrew D Cox; E Richard Moxon; James C Richards
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 2.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 3.  Evolutionary and genomic insights into meningococcal biology.

Authors:  Holly B Bratcher; Julia S Bennett; Martin C J Maiden
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

4.  Impact of Moderate Temperature Changes on Neisseria meningitidis Adhesion Phenotypes and Proteome.

Authors:  Martin Lappann; Andreas Otto; Madita Brauer; Dörte Becher; Ulrich Vogel; Kay Johswich
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 5.  Review of meningococcal group B vaccines.

Authors:  Dan M Granoff
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

6.  The amino acid sequence of Neisseria lactamica PorB surface-exposed loops influences Toll-like receptor 2-dependent cell activation.

Authors:  Deana N Toussi; Margaretha Carraway; Lee M Wetzler; Lisa A Lewis; Xiuping Liu; Paola Massari
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

7.  Neisseria lactamica antigens complexed with a novel cationic adjuvant.

Authors:  Emanuelle B Gaspar; Andreza S Rosetti; Nilton Lincopan; Elizabeth De Gaspari
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

8.  Commensal Neisseria Kill Neisseria gonorrhoeae through a DNA-Dependent Mechanism.

Authors:  Won Jong Kim; Dustin Higashi; Maira Goytia; Maria A Rendón; Michelle Pilligua-Lucas; Matthew Bronnimann; Jeanine A McLean; Joseph Duncan; David Trees; Ann E Jerse; Magdalene So
Journal:  Cell Host Microbe       Date:  2019-08-01       Impact factor: 21.023

Review 9.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB.

Authors:  Julia S Bennett; Martin J Callaghan; Jeremy P Derrick; Martin C J Maiden
Journal:  Microbiology (Reading)       Date:  2008-05       Impact factor: 2.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.